164 related articles for article (PubMed ID: 21808225)
1. Preparation, purification, and characterization of lanthanide complexes for use as contrast agents for magnetic resonance imaging.
Averill DJ; Garcia J; Siriwardena-Mahanama BN; Vithanarachchi SM; Allen MJ
J Vis Exp; 2011 Jul; (53):. PubMed ID: 21808225
[TBL] [Abstract][Full Text] [Related]
2. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
[TBL] [Abstract][Full Text] [Related]
3. Modulating water-exchange rates of lanthanide(III)-containing polyaminopolycarboxylate-type complexes using polyethylene glycol.
Siriwardena-Mahanama BN; Allen MJ
Dalton Trans; 2013 May; 42(19):6724-7. PubMed ID: 23584014
[TBL] [Abstract][Full Text] [Related]
4. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
[TBL] [Abstract][Full Text] [Related]
5. Novel polycarboxylated EDTA-type cyclodextrins as ligands for lanthanide binding: study of their luminescence, relaxivity properties of Gd(iii) complexes, and PM3 theoretical calculations.
Maffeo D; Lampropoulou M; Fardis M; Lazarou YG; Mavridis IM; Mavridou DA; Urso E; Pratsinis H; Kletsas D; Yannakopoulou K
Org Biomol Chem; 2010 Apr; 8(8):1910-21. PubMed ID: 20449498
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a lanthanide complex encapsulated with MRI contrast agents into liposomes for biosensor imaging of redundant deviation in shifts (BIRDS).
Maritim S; Huang Y; Coman D; Hyder F
J Biol Inorg Chem; 2014 Dec; 19(8):1385-98. PubMed ID: 25304046
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of dinuclear heterometallic lanthanide complexes exhibiting MRI and luminescence response.
Mamedov I; Parac-Vogt TN; Logothetis NK; Angelovski G
Dalton Trans; 2010 Jun; 39(24):5721-7. PubMed ID: 20485819
[TBL] [Abstract][Full Text] [Related]
8. Cyclen lanthanide-based micellar structures for application as luminescent [Eu(iii)] and magnetic [Gd(iii)] resonance imaging (MRI) contrast agents.
Surender EM; Comby S; Martyn S; Cavanagh B; Lee TC; Brougham DF; Gunnlaugsson T
Chem Commun (Camb); 2016 Sep; 52(72):10858-61. PubMed ID: 27523566
[TBL] [Abstract][Full Text] [Related]
9. Strategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging.
Siriwardena-Mahanama BN; Allen MJ
Molecules; 2013 Aug; 18(8):9352-81. PubMed ID: 23921796
[TBL] [Abstract][Full Text] [Related]
10. The importance of water exchange rates in the design of responsive agents for MRI.
Sherry AD; Wu Y
Curr Opin Chem Biol; 2013 Apr; 17(2):167-74. PubMed ID: 23333571
[TBL] [Abstract][Full Text] [Related]
11. New tris-3,4-HOPO lanthanide complexes as potential imaging probes: complex stability and magnetic properties.
Mendonça AC; Martins AF; Melchior A; Marques SM; Chaves S; Villette S; Petoud S; Zanonato PL; Tolazzi M; Bonnet CS; Tóth É; Di Bernardo P; Geraldes CF; Santos MA
Dalton Trans; 2013 May; 42(17):6046-57. PubMed ID: 23296398
[TBL] [Abstract][Full Text] [Related]
12. De Novo Designed Imaging Agents Based on Lanthanide Peptides Complexes.
Peacock AF
Methods Enzymol; 2016; 580():557-80. PubMed ID: 27586349
[TBL] [Abstract][Full Text] [Related]
13. A robust and convergent synthesis of dipeptide-DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents.
Wojciechowski F; Suchy M; Li AX; Azab HA; Bartha R; Hudson RH
Bioconjug Chem; 2007; 18(5):1625-36. PubMed ID: 17711349
[TBL] [Abstract][Full Text] [Related]
14. Development of responsive lanthanide-based magnetic resonance imaging and luminescent probes for biological applications.
Hanaoka K
Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1283-94. PubMed ID: 20930392
[TBL] [Abstract][Full Text] [Related]
15. DOTAM-type ligands possessing arginine pendant groups for use in PARACEST MRI.
Suchý M; Li AX; Milne M; Bartha R; Hudson RH
Contrast Media Mol Imaging; 2012; 7(5):441-9. PubMed ID: 22821878
[TBL] [Abstract][Full Text] [Related]
16. Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes.
Woods M; Kovacs Z; Zhang S; Sherry AD
Angew Chem Int Ed Engl; 2003; 42(47):5889-92. PubMed ID: 14673928
[No Abstract] [Full Text] [Related]
17. Coordination-Assembled Water-Soluble Anionic Lanthanide Organic Polyhedra for Luminescent Labeling and Magnetic Resonance Imaging.
Wang Z; He L; Liu B; Zhou LP; Cai LX; Hu SJ; Li XZ; Li Z; Chen T; Li X; Sun QF
J Am Chem Soc; 2020 Sep; 142(38):16409-16419. PubMed ID: 32882131
[TBL] [Abstract][Full Text] [Related]
18. Lanthanides in magnetic resonance imaging.
Bottrill M; Kwok L; Long NJ
Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
[TBL] [Abstract][Full Text] [Related]
19. Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging.
Siddiqui TS; Jani A; Williams F; Muller RN; Vander Elst L; Laurent S; Yao F; Wadghiri YZ; Walters MA
J Colloid Interface Sci; 2009 Sep; 337(1):88-96. PubMed ID: 19527906
[TBL] [Abstract][Full Text] [Related]
20. Redox-activated MRI contrast agents based on lanthanide and transition metal ions.
Tsitovich PB; Burns PJ; McKay AM; Morrow JR
J Inorg Biochem; 2014 Apr; 133():143-54. PubMed ID: 24529651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
